Biotechnology

VIVUS, Inc. today announced that it will report financial results for the second quarter ended June 30, 2010 after the NASDAQ Market closes on Monday, August 2, 2010.

Cyclacel Pharmaceuticals, Inc. , will announce second quarter 2010 financial results on Thursday, August 5, 2010. The Company will host a conference call and live webcast at 4:30 pm Eastern time on the same day.

Osiris Therapeutics, Inc. today announced that it will report its financial results for the quarter ended June 30, 2010, on Friday, August 6, 2010. C. Randal Mills, Ph.D., President and Chief Executive Officer, and Philip R. Jacoby, Jr., Chief ...

NeoGenomics, Inc. , a leading provider of cancer-focused genetic testing services today reported its results for the second quarter 2010.

Omeros Corporation today announced that it has secured a committed equity financing facility under which it may sell up to $40 million of its shares of common stock to Azimuth Opportunity, Ltd. over a 24-month period. Omeros is not obligated to use ...

Isis Pharmaceuticals, Inc. announced today that it has earned a $5 million milestone payment from GlaxoSmithKline related to the designation as a development candidate of a drug to treat an undisclosed rare and serious disease. Isis will develop ...

Leading UHF Gen 2 radio frequency identification technology provider Impinj, Inc. today introduced the Indy® R500 reader chip, developed specifically to address the emerging market for low-cost hand-held, desktop and embedded RFID readers. ...

Antigenics Inc. reported today its results for the quarter ended June 30, 2010. The company incurred a net loss attributable to common stockholders of $5.2 million, or $0.05 per share, basic and diluted, for the second quarter of 2010, compared ...